GSK’s antibody-drug conjugate strategy may be making more headlines recently, but the British pharma hasn’t forgotten about ...

GSK is shelling out $85 million up front, and possibly $745 million overall, for an RNA-based therapy it sees helping a ...

November is COPD Awareness Month, and Day to Day is playing our part in spreading knowledge and resources about the chronic ...

Medication treatment for COPD usually involves inhaled medications, such as beta agonists like albuterol or long-acting forms ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. COPD exacerbations went down by 51% in patients with ...

Fewer than 1 in 5 patients with COPD receive the recommended levels of care, with nearly 1 in 4 waiting more than 5 years to be diagnosed, research has shown. The new research, from lung charity ...

Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that causes inflammation and lung damage. Lifestyle changes such as an anti-inflammatory diet and supplements can help manage ...

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Oxygen therapy for COPD is a treatment used to increase the oxygen in your lungs and bloodstream. Research suggests that people with chronic obstructive pulmonary disease (COPD) who use oxygen may ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.